We read with great interest the article of Pan et al. who identified a new member of *Anelloviridae* family, named torque teno mini virus (TTMV)-SH, in the serum of 3/19 Hodgkin's lymphoma patients tested. This virus was not found in non-Hodgkin lymphoma nor in healthy donor samples, suggesting that TTMV-SH may be associated with this type of hematological malignancy ([@ref8]).

Objective of the Study and Clinical Samples Collection {#sec1}
======================================================

We aimed to investigate the presence of TTMV-SH virus in a large collection of 286 plasma samples collected from patients (*n* = 72) with various hematological diseases as well as in 37 healthy donor samples. Seventy-two patients suffering from multiple myeloma (MM, *n* = 42), non-Hodgkin's lymphoma (NHL, *n* = 20), or acute myeloid leukemia (AML, *n* = 10) were included in the cohort at diagnosis. In addition, 214 MM patient samples were collected prospectively up to 90 days after autologous stem-cell transplantation (ASCT, median follow-up: 255 days). Of note, MM and AML were not investigated in the study reported by Pan et al.

Viral Metagenomics and Bioinformatical Analysis {#sec2}
===============================================

Metagenomic analysis of plasma samples was performed using a validated workflow ([@ref1]). Briefly, samples were centrifuged, filtered, and treated with DNase to reduce the human and bacterial components. Total nucleic acid was then extracted, randomly amplified, and prepared using Nextera XT DNA Library preparation kit according to the manufacturer's recommendations (Illumina, San Diego, CA, USA). Libraries were sequenced on the Illumina Next Seq 500 platform with a median sequencing depth of 27,146,137 reads per sample. To retrieve potential sequences belonging to TTMV-SH virus, non-human NGS reads were first mapped on the complete genome of TTMV-SH published by [@ref8] using discontinuous megaBLAST. Selected reads were then aligned on the TTMV-SH ORF1 sequence with BBmap (version 36.32). The ORF1 consensus sequence was generated for each isolate and deposited in GenBank database under the accession numbers MN249910 to MN249933.

Identification of Torque Teno Mini Virus-SH-Related Strains {#sec3}
===========================================================

TTMV-SH-related strains, with the entire major coding region (ORF1) covered, were identified in 24 samples (median number of TTMV-SH-related reads detected: 52,189/sample). These 24 samples were collected from a total of five patients with MM (*n* = 4) and NHL (*n* = 1). For 2 MM patients, TTMV-SH-related viruses were identified in, respectively, 10 and 11 successive samples collected from diagnosis up to 90 days post-ASCT. Interestingly, TTMV-SH-related viruses were not detected in any of the 37 healthy donor samples tested. Phylogenic analysis revealed that the 24 isolates were genetically close to the TTMV-SH strains identified by Pan et al., sharing 79.6--86.7% ORF1 nucleotide sequence identity (i.e., sequence divergence ranging from 13.3 to 20.4%; [Figure 1](#fig1){ref-type="fig"}). According to the International Committee on Taxonomy of Viruses (ICTV), *Anelloviridae* species demarcation criteria are based on \>35% cutoff value in nucleotide sequence divergence of the entire ORF1 \[[@ref5]\]. Consequently, the results herein suggest that TTMV-SH-related viruses, belonging to the same cluster of species as Pan et al., might be found in hematological diseases other than Hodgkin's lymphoma.

![Phylogenetic analysis of TTMV strains based on the nucleotide sequence ORF1. TTMV sequences deposited in GenBank were downloaded. Four reference sequences of TTV and TTMDV strains were also used. Genetic distances were calculated with the Jukes-Cantor model of evolution. The tree was constructed by the neighbor-joining method using Geneious 10.0.7 software (Biomatters Ltd., Auckland, New Zealand) and validated using 1,000 bootstrap pseudo-replicates. Bootstrap values are indicated at each branching point. Scale bars indicate number of nucleotide substitutions per site. The green sequences indicate the 11 TTMV strains reported by [@ref8]. The red sequences indicate the 12 TTMV species defined by ICTV. TTMV-SH-related sequences identified in the present study (*n* = 24) were represented by a different color for each patient (*n* = 5).](fmicb-10-01898-g001){#fig1}

Discussion {#sec4}
==========

The complex relationship between the immune system and the viral replication cycle, as well as the high rate of recombination and mutation events, are responsible for a very high genetic variability within *Anelloviridae* species ([@ref9]). To date, 12 TTMV species have been approved by ICTV in the *betatorquevirus* genus \[[@ref5]\] but we can hypothesize that additional species might be defined in the future.

The recent development of viral metagenomic approaches has allowed to enhance the characterization of *Anelloviridae* genetic diversity. Metagenomics contributed to identify new *Anelloviridae* genotypes in patients suffering from various diseases including Kawasaki disease, brain cancer, encephalitis, and periodontitis ([@ref11]; [@ref7]; [@ref10]; [@ref2]). Due to their extreme genetic heterogeneity, it is possible that a new *Anelloviridae* strain could be characterized during particular medical conditions using metagenomic testing. Notably in case of compromised immune system, the *Anelloviridae* replication rate could be very high ([@ref4]) which may favor the emergence of a new genotype. However, the characterization of a new virus in patients suffering from a specific disease may not be sufficient to demonstrate an association and even less a causation.

As underlined by the study reported by Pan et al., the impact of viruses on cancer development should continue to be explored in larger cohorts even if the role of *Anelloviridae* may be difficult to establish. Furthermore, longitudinal studies are required to demonstrate a specific temporal association between a disease and a particular strain, as suggested by Koch's postulates, revisited for molecular and metagenomics data ([@ref3]; [@ref6]).
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